首页> 外文期刊>Applied Microbiology >Relationship between Antimicrobial Susceptibility and Multilocus Sequence Type of Mycoplasma bovis Isolates and Development of a Method for Rapid Detection of Point Mutations Involved in Decreased Susceptibility to Macrolides, Lincosamides, Tetracyclines, and Spectinomycin
【24h】

Relationship between Antimicrobial Susceptibility and Multilocus Sequence Type of Mycoplasma bovis Isolates and Development of a Method for Rapid Detection of Point Mutations Involved in Decreased Susceptibility to Macrolides, Lincosamides, Tetracyclines, and Spectinomycin

机译:牛肺炎支原体分离物的抗菌药敏感性与多基因座序列类型之间的关系以及快速检测点突变的方法的开发,该方法涉及对大环内酯类,林可酰胺,四环素和壮观霉素的敏感性降低

获取原文

摘要

Mycoplasma bovis isolates belonging to the sequence type 5 (ST5) group, the dominant group in Japan since 1999, were low susceptible to 16-membered macrolides and tetracyclines and were confirmed to have a guanine-to-adenine transition mutation at position 748 in the 23S rRNA gene (rrl) and adenine-to-thymine transversion mutations at positions 965 and 967 in the 16S rRNA gene (rrs) (Escherichia coli numbering). Moreover, isolates of ST93 and ST155, members of the ST5 group, were low susceptible to lincosamides and azithromycin and showed an adenine-to-guanine transition mutation at position 2059 of rrl. Isolates of ST93 were additionally low susceptible to spectinomycin and showed a cytosine-to-adenine transversion mutation at position 1192 of rrs. Strains of the ST5 group seem to spread to Japan and Europe from North America with imported cows, while strains of ST93 and ST155 originated in Japan. Melting curve analysis using hybridization probes revealed the existence of point mutations involved in decreased susceptibility to macrolides, lincosamides, and spectinomycin, as demonstrated by changes in the melting curve shape and/or decreases in the melting peak temperature, so the susceptibility to these antimicrobials can be assessed on the same day. For decreased susceptibility to fluoroquinolones to exist, nonsynonymous mutations in the DNA gyrase gene (gyrA) and topoisomerase IV gene (parC) had to coexist. The combination of amino acid substitutions of serine at position 83 in gyrA and serine at position 80 in parC resulted in particularly low susceptibility to fluoroquinolones.IMPORTANCEMycoplasma bovis is the main causal species of bovine mycoplasmal disease and leads to significant economic losses because of its severe symptoms, strong infectivity, and refractoriness. As for mastitis, culling cows with intramammary infections is a general countermeasure to prevent spreading. The conventional antimicrobial susceptibility test for mycoplasma is time-consuming and troublesome, but no quick and easy method for grasping the antimicrobial susceptibility of the causal strain exists at present. Treatment without antimicrobial susceptibility information may be one reason why M. bovis infection is refractory. Detecting a mutation involved in decreased susceptibility to antimicrobial agents of the causal strain makes it possible to easily select suitable antimicrobials for treatment, and this technique will help improve the cure rate and prevent the overuse of ineffective antimicrobial agents. In this study, we developed a technique to quickly and easily assess antimicrobial susceptibility based on the genetic characteristics of M. bovis strains in Japan.
机译:自1999年以来在日本占主导地位的序列类型5(ST5)组的牛支原体分离株对16元大环内酯类和四环素类药物敏感度较低,并且已确认在其第748位具有鸟嘌呤-腺嘌呤过渡突变。 16S rRNA基因(rrs)中965和967位的23S rRNA基因(rrl)和腺嘌呤至胸腺嘧啶的转化突变(大肠杆菌编号)。此外,ST5组成员ST93和ST155的分离株对林可酰胺和阿奇霉素的敏感性较低,并在rrl的2059位显示出腺嘌呤向鸟嘌呤的转变突变。 ST93的分离株对壮观霉素的敏感性较低,并且在rrs的1192位显示胞嘧啶向腺嘌呤的转化突变。 ST5组的菌株似乎是通过进口奶牛从北美传播到日本和欧洲的,而ST93和ST155菌株则起源于日本。使用杂交探针进行的熔解曲线分析显示,存在点突变,导致对大环内酯类,林可酰胺类和壮观霉素的敏感性降低,这通过熔解曲线形状的变化和/或熔解峰温度的降低证明,因此对这些抗微生物剂的敏感性可以在同一天进行评估。为了降低对氟喹诺酮类药物的敏感性,必须在DNA旋转酶基因(gyrA)和拓扑异构酶IV基因(parC)中共存同义突变。在gyrA中第83位的丝氨酸和parC中第80位的丝氨酸的氨基酸取代结合在一起,导致对氟喹诺酮类药物的敏感性特别低。 ,强烈的传染性和耐火度。至于乳腺炎,淘汰带有乳内感染的母牛是防止传播的一般对策。常规的支原体抗菌药敏试验既费时又麻烦,但目前尚无快速简便的方法来掌握因果菌株的抗菌药敏性。没有抗菌药敏感性信息的治疗可能是牛分枝杆菌感染难治的原因之一。检测引起对因果菌株的抗微生物剂敏感性降低的突变使得可以容易地选择合适的抗微生物剂进行治疗,并且该技术将有助于提高治愈率并防止过度使用无效的抗微生物剂。在这项研究中,我们开发了一种技术,可以根据日本M. bovis菌株的遗传特征快速轻松地评估抗菌药的敏感性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号